NCT03561779View on ClinicalTrials.gov

Clinical Trial of YYD302 (Phase3) for Treatment of Osteoarthritis of the Knee

PHASE3CompletedINTERVENTIONAL
Enrollment

184

Participants

Timeline

Start Date

February 21, 2018

Primary Completion Date

June 14, 2019

Study Completion Date

October 4, 2019

Conditions
Osteoarthritis, Knee
Interventions
DRUG

YYD302 2ml

YYD302 2ml

DRUG

Active comparator: Synovian Inj.

Active comparator: Synovian Inj.

Trial Locations (1)

Unknown

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Yooyoung Pharmaceutical Co., Ltd.

INDUSTRY

NCT03561779 - Clinical Trial of YYD302 (Phase3) for Treatment of Osteoarthritis of the Knee | Biotech Hunter | Biotech Hunter